Home > Income Statement > WANBURY

WANBURY
Revenue

    Back to Income Statement
WANBURY is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for WANBURY
Please provide your vote to see the results

WANBURY Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹500 Cr₹511 Cr₹393 Cr₹367 Cr₹391 Cr

What is the latest Revenue of WANBURY ?

The latest Revenue ratio of WANBURY is ₹500 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹500 Cr
Mar2023₹511 Cr
Mar2022₹393 Cr
Mar2021₹367 Cr
Mar2020₹391 Cr

How is Revenue of WANBURY Trending?

Years Revenue % Change
Mar2024 ₹500 Cr
-2.26
Mar2023 ₹511 Cr
30.23
Mar2022 ₹393 Cr
6.82
Mar2021 ₹367 Cr
-6.11
Mar2020 ₹391 Cr -

Compare Revenue of peers of WANBURY

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WANBURY ₹945.9 Cr 14.1% 8% 38.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹393,419.0 Cr -0.2% -2.3% -7.4% Stock Analytics
DIVIS LABORATORIES ₹159,986.0 Cr -1.7% -8.8% 27.2% Stock Analytics
CIPLA ₹128,659.0 Cr 1.9% 8.7% -1.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹123,448.0 Cr 0.7% 4.1% 8.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,539.0 Cr 1.4% 2.9% -10.6% Stock Analytics


WANBURY Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
WANBURY

14.1%

8%

38.8%

SENSEX

1.8%

-0.2%

2%


You may also like the below Video Courses